BIODEL INC (BIOD)

Overview Price 0.64 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $0.64 Daily Range $0.00 - $0.00 52-Week Range $0.51 - $2.59 Volume 0 BIODEL INC. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel's product candidates are developed by using VIAdel(TM) technology, which reformulates existing FDA-approved peptide drugs. The Company's lead product candidate, VIAject(TM), is an ultra rapid-acting injectable meal-time insulin in development for use by patients with Type 1 or Type 2 diabetes. VIAject(TM) is currently being tested in two pivotal Phase III clinical trials. Biodel's pipeline also includes VIAtab(TM), a sublingual tablet formulation of insulin in the Phase I stage of clinical testing, and two pre-clinical osteoporosis product candidates. Other Resources for BIOD Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Zacks #1 Rank Additions for Wednesday October 19, 2011 Zacks Blog: Zacks #1 Rank Additions for Friday October 14, 2011 BIODEL INC. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel's product candidates are developed by using VIAdel(TM) technology, which reformulates existing FDA-approved peptide drugs. The Company's lead product candidate, VIAject(TM), is an ultra rapid-acting injectable meal-time insulin in development for use by patients with Type 1 or Type 2 diabetes. VIAject(TM) is currently being tested in two pivotal Phase III clinical trials. Biodel's pipeline also includes VIAtab(TM), a sublingual tablet formulation of insulin in the Phase I stage of clinical testing, and two pre-clinical osteoporosis product candidates.   Brokerage Analyst Recommendations 5 Brokerage Firms Covering BIOD   Strong Buy 1 Buy 0 Hold 4 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 2.6   BIOD Ratings: BUY  SELL  HOLD BIOD Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 1 Buy 0 Sell   Top Buy Analysis BUY: BIOD Company: BIODEL INC Points: -106.71 Start Price: $5.27 Start Date: 09/21/2010 1:53 AM BIGZEE P&P Score: 0.83 Recs: hi hi Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
zantriocom	0.00	06/28/10	Zantrio.com Free Daily Stock Picks 6-28-2010	0
Zacks_Analysts	0.00	12/13/10	Loss at BIOD Narrower than Expected - Analyst Blog	0

Commentary

BUY: BIODEL INC (BIOD) Start Price: $5.27 Points: -106.71 Created: 09/21/2010 hi hi Comments: 0 | Comment BIGZEE Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
BIGZEE	0.83	BUY	Week or Less	09/21/2010	$5.27	$0.62 (-1.03%)	-88.29%	+18.42%	-106.71	view close